Effects of Combined Segmental Vibrator and Neuromuscular Electrical Stimulation in Subacute Stroke

NCT ID: NCT06686303

Last Updated: 2025-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-12-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke is leading cause of death and disability worldwide, resulting in significant functional limitations and disabilities experienced by stroke survivors, particularly in the upper limb. There is a need for more effective interventions targeting upper limb sensory motor impairments. The aim of this study is to study combined effect of segmental vibrator and neuromuscular electrical stimulation for flexor and extensor muscle groups on upper limb function in sub-acute stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be a randomized clinical trial and will be conducted in physiotherapy department of Allama Iqbal Memorial Teaching Hospital Sialkot, National Bone and Joint Hospital and Bashir Hospital Sialkot. Forty stroke patients will be recruited through non-probability convenience sampling technique and will be randomly divided in two equal groups Group A and group B through lottery method. Group A will receive high frequency segmental vibration on flexor and extensor muscle groups while group B will receive neuromuscular electrical stimulation along with high frequency segmental vibration(100Hz) on flexor and extensor muscle groups Data will be collected from patients of sub-acute stroke by using screening tool MoCA(for cognition) and assessment tools Fugl-Meyer Assessment Scale(for upper limb function), Wolf Motor Functional Test(for motor function), Modified Ashworth Scale(for spasticity) , Barthel Index(for ADLs), Maximal Hand Grip Strength(for manual dexterity), Maximal Pinch Grip(for manual dexterity), Nottingham Sensory Assessment(for somatosensory function). An informed consent will be taken. Outcome measures will be assessed at baseline, at 4th week and at 8th week. Follow up will be performed at 12th week. Data analysis will be done by SPSS version 28.0.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subacute Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Group A received the high frequency segmental vibrator.

Group Type EXPERIMENTAL

High frequency Segmental Vibrator

Intervention Type OTHER

Segmental vibrations of high frequency was used on each flexor and extensor interspersed with a 1 minute break.

Group B

Group B received the combined effects of high frequency segmental vibrator and neuromuscular electrical stimulation.

Group Type EXPERIMENTAL

Combined effects of high frequency segmental vibrator and neuromuscular electrical stimulation.

Intervention Type OTHER

Segmental vibrations of high frequency with Neuromuscular Electrical Stimulation was given on each flexor and extensor.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High frequency Segmental Vibrator

Segmental vibrations of high frequency was used on each flexor and extensor interspersed with a 1 minute break.

Intervention Type OTHER

Combined effects of high frequency segmental vibrator and neuromuscular electrical stimulation.

Segmental vibrations of high frequency with Neuromuscular Electrical Stimulation was given on each flexor and extensor.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both genders
* Aged between 45 and 65 years old
* First ever ischemic stroke experienced more than 3 months before the enrollment
* Spasticity of spastic agonist muscles ranging from 0-2 on the MAS

Exclusion Criteria

* Patients with bilateral brain lesions
* Ischemic involvement of cerebellum or basal ganglia
* Psychiatric disease and cognitive impairment
* Previous history of other neurological diseases,rheumatic and orthopaedic conditions
* Patients under anti-spastic therapy or other clinical trials
* Metal implants e.g. cardiac pacemakers
Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aruba Saeed, MS-NMPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Bone and Joint Hospital

Sialkot, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/0216 RabiaSaleem

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.